Ingevity Corporation
NGVTBasic MaterialsNASDAQSpecialty Chemicals
Scan Results
Daily timeframePart of the basic materials sector, Ingevity Corporation (NGVT) is listed under Specialty Chemicals. The company carries a $2.39B market cap, placing it firmly in the mid-cap category. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.
Market Cap
$2.39B
Beta
1.14
P/E (TTM)
99.49
P/E (Fwd)
11.58
EPS (TTM)
$0.70
EPS (Fwd)
$6.01
ROE
30.1%
ROA
10.4%
Cash
$97.4M
Total Debt
$1.24B
Free CF
$88.9M
52W Change
21.8%
Annual Financials
Cash vs Debt
Where NGVT stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, NGVT finished 1.94% below its 150-day moving average ($71.70) and 0.79% below its 200-day moving average ($70.87). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is NGVT overbought or oversold?
At the October 20, 2026 close, NGVT's RSI(14) was 46.4, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $97.4M in cash, though total debt stands at $1.24B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $88.9M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at 30.1%, which is exceptionally high for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. Return on assets of 10.4% further supports the picture of efficient asset utilization. Revenue has pulled back from $1.67B (2022) to $1.17B (2025), a 30% decline worth watching.
Ingevity Corporation carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. The elevated P/E ratio means the stock is priced for significant future growth. If earnings disappoint, the price correction could be sharp. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Ingevity Corporation's trajectory.